New York, New York, United States The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.
The current fund was established by Brett Leve, Brock Saunders, Carlos Rivera, Elliott Bisnow, Hamad Alwazzan, Jeff Rosenthal, Jeremy Schwartz. The overall number of key employees were 4.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Uber, Clover Health, Warby Parker. Among the most successful fund investment fields, there are Health Care, Search Engine. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 1 or 5+ of the founder, the chance for it to get the investment is meager.
The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Summit Action, startups are often financed by Lowercase Capital, First Round Capital, Upfront Ventures. The meaningful sponsors for the fund in investment in the same round are Valia Ventures, Upfront Ventures, Refactor Capital. In the next rounds fund is usually obtained by ff Venture Capital, GV, Bullish.
Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The typical startup value when the investment from Summit Action is 100-500 millions dollars. Comparing to the other companies, this Summit Action performs on 16 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2019. The high activity for fund was in 2011. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Agro Innovation Lab Gmbh | Austria, Vienna |
| Arthurian Life Sciences | England, London, United Kingdom |
| Blackstone Alternative Asset Management | New York, New York, United States |
| Centre for Commercialization of Cancer Immunotherapy | Canada, Montréal, Quebec |
| Chengdu Zhengjian | Chengdu, China, Sichuan |
| Daishin Securities | Seoul, Seoul-t'ukpyolsi, South Korea |
| Daxinli Touzi | Beijing, Beijing, China |
| GTG Ventures | California, Palo Alto, United States |
| Hubei Provincial High Technology Industry Investment Co., Ltd. | China, Hubei, Wuhan |
| Leo Capital Holdings | Illinois, Northbrook, United States |
| Mechanics Bank | California, Richmond, United States |
| Nextlaw Ventures | California, Palo Alto, United States |
| Nippon Technology Venture Partners | Japan, Setagaya |
| Ocmcapital | Beijing, Beijing, China |
| Quadrise Canada Corporation | Alberta, Calgary, Canada |
| R-301 Capital | Lugano, Switzerland, Ticino |
| Rockstart AI | 's-Hertogenbosch, Netherlands, North Brabant |
| Shulian Touzi | Chengguan District, China, Lhasa |
| The Boeing Company | Chicago, Illinois, United States |
| Traversant | Arizona, Phoenix, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ometria | $40M | 11 Nov 2021 | London, England, United Kingdom | ||
Ometria | $21M | 23 Sep 2019 | United Kingdom, England | ||
Shield Bio | $8M | 23 May 2018 | San Jose, California, United States | ||
Ometria | $6M | 11 Oct 2017 | England | ||
Ready | $700K | 21 Jul 2017 | New Orleans, Louisiana, United States | ||
MakeSpace | $30M | 20 Apr 2017 | New York, New York, United States | ||
Triplemint | $4M | 23 Feb 2017 | New York, New York, United States | ||
Zenrez | $2M | 11 Jul 2016 | United States, San Francisco | ||
Clover Health | $160M | 20 May 2016 | Nashville, Tennessee, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ometria | $40M | 11 Nov 2021 | London, England, United Kingdom | ||
Ometria | $21M | 23 Sep 2019 | United Kingdom, England | ||
Shield Bio | $8M | 23 May 2018 | San Jose, California, United States | ||
Ometria | $6M | 11 Oct 2017 | England | ||
Ready | $700K | 21 Jul 2017 | New Orleans, Louisiana, United States | ||
MakeSpace | $30M | 20 Apr 2017 | New York, New York, United States | ||
Triplemint | $4M | 23 Feb 2017 | New York, New York, United States | ||
Zenrez | $2M | 11 Jul 2016 | United States, San Francisco | ||
Clover Health | $160M | 20 May 2016 | Nashville, Tennessee, United States |
